Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Z. Jaidane"'
Autor:
Faouzi Addad, Z. Jaidane, H Ben Limam, A. Kasab, Wissem Mnif, M.Y. Hrira, Mohsen Kerkeni, S. Ferchichi, Abdelhedi Miled, Sandrine Laradi
Publikováno v:
Immuno-analyse & Biologie Spécialisée. 26:107-112
Summary C-reactive protein ultrasensitive (CRPus) is a member of very old and very conserved pentraxines family. It is characterized by homopentameric structure. It is considered as a crucial endogen peptide in evaluation of cardiovascular diseases r
Autor:
I. Gammoudi, S. Ferchichi, A. Chalghoum, A. Miled, A. Dandana, Y. Noichri, S. Khelil, Z. Jaidane, H. Chahed, S. Ernez, G. Jeridi
Publikováno v:
Immuno-analyse & Biologie Spécialisée. 25:191-196
Summary Background An imbalance between production of free radicals and oxidative protection in association with the coronary decease and their consequences such heart failure (HF). The aim of this study was to confirm the assumption of the impact of
Autor:
H. Bouraoui, A. Miled, Z. Jaidane, H. Ammar, H. Ben Limem, S. Ferchichi, H. Chahed, A. Dandana
Publikováno v:
Immuno-analyse & Biologie Spécialisée. 25:171-178
Summary Background Heart failure is a major public health problem and despite significant advances in treatment remains the only cardiovascular disease still on the rise. It has long been known to carry a poor prognosis. On the other hand, B-type nat
Autor:
Latifa Chkioua, Y. Chaabouni, A. Chalghoum, A. Dandana, H. Chahed, Y. Noichri, S. Khelil, S. Ferchichi, Z. Jaidane, I. Gammoudi, A. Miled, G. Jeridi
Publikováno v:
Immuno-analyse & Biologie Spécialisée. 25:185-190
Summary Background The acute coronary syndromes (ACS) are polygenic and complex pathologies. The increase of angiotensin I converting enzyme (ACEI) activity and homocysteinemia (hcy) are supposed to be risk factor. Aim To evaluate the ACEI activity a
Autor:
H. Chahed, H. Khairi, Y. Chaabouni, A. Miled, N. Saafi, S. Ferchichi, Sandrine Laradi, H.B. Limem, M. Bernard, Z. Jaidane, M. Sakouhi
Publikováno v:
Immuno-analyse & Biologie Spécialisée. 25:205-211
Summary Maternal marker screening for Down's syndrome is based on an individual risk calculation obtained by weighting the risk due to maternal age by a factor linked to maternal serum markers. The maternal serum markers used in our study are alpha-f
Autor:
H. Chahed, S. Ernez, G. Jeridi, S. Ferchichi, I. Gammoudi, Z. Jaidane, S. Khelil, A. Dandana, Y. Chaabouni, A. Miled, A. Chalghoum, Y. Noichri
Publikováno v:
Immuno-analyse & Biologie Spécialisée. 25:135-139
Summary Objective The present study was undertaken to evaluate the variation of the parameters of antioxidant and oxidant status in coronary smokers Tunisian patients. Patients and methods We made this study on 72 patients with unstable angina (UA) c
Autor:
Z. Jaidane, A. Miled, I. Maire, Roseline Froissart, Latifa Chkioua, H. Chahed, S. Wesleti, S. Khedhiri, Sandrine Laradi, S. Ferchichi
Publikováno v:
Immuno-analyse & Biologie Spécialisée. 25:38-42
Summary Hurler's syndrome or mucopolysaccharidosis type IH (MPS IH) is the most severe form of mucopolysaccharidosis type I (MPS I). It is caused by the deficiency of the alpha- l -iduronidase (IDUA) activity. The accumulation of undegraded MPS affec
Autor:
Latifa Chkioua, Roseline Froissart, I. Maire, S. Ferchichi, S. Ben Khelifa, V. Bonnet, Sandrine Laradi, A. Dandana, K Monastiri, A. Miled, Z. Jaidane
Publikováno v:
Pathologie Biologie. 56:88-93
Gaucher disease is one of the most prevalent lysosomal disorders. In this present study, we report a diagnostic strategy of type 1 Gaucher disease. The application of combined methods in molecular biology allowed us to analyse the p.Asn 370 Ser mutat
Autor:
V. Bonnet, I. Maire, Roseline Froissart, H.B. Limem, Latifa Chkioua, M. Abdelhedi, S. Khedhiri, Z. Jaidane, Sandrine Laradi, M. Chaabouni, A. Dandana, S. Habib, T. Jrad, S. Ferchichi
Publikováno v:
Archives de Pédiatrie. 14:1183-1189
Resume La mucopolysaccharidose de type I (MPS I) est une maladie de surcharge lysosomale, due au deficit en α-L-iduronidase (IDUA). C'est une maladie grave avec un spectre clinique heterogene comportant des atteintes progressives viscerales, osseuse
Autor:
Nicolas Ferry, A Myara, Marta Bellodi-Privato, Maude Flageul, Dominique Aubert, Virginie Pichard, Tuan Huy Nguyen, Z Jaidane-Abdelghani
Publikováno v:
Gene therapy. 14(17)
Among inherited diseases of the liver, Crigler-Najjar type 1 disease (CN-1), which results from complete deficiency in bilirubin UDP-glucuronosyltransferase activity (B-UGT1), is an attractive target for gene therapy studies. Hyperbilirubinemic Gunn